Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo.

Romi F, Kristoffersen EK, Aarli JA, Gilhus NE.

J Neuroimmunol. 2005 Jan;158(1-2):191-4.

PMID:
15589053
2.

The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.

Romi F, Skeie GO, Aarli JA, Gilhus NE.

Arch Neurol. 2000 Nov;57(11):1596-600.

PMID:
11074791
3.

Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.

Shelton GD, Skeie GO, Kass PH, Aarli JA.

Vet Immunol Immunopathol. 2001 Jan 10;78(1):97-105.

PMID:
11182151
4.

Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations.

Romi F, Skeie GO, Vedeler C, Aarli JA, Zorzato F, Gilhus NE.

J Neuroimmunol. 2000 Nov 1;111(1-2):169-76.

PMID:
11063835
5.

Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies.

Skeie GO, Romi F, Aarli JA, Bentsen PT, Gilhus NE.

Ann N Y Acad Sci. 2003 Sep;998:343-50. Review.

PMID:
14592894
6.

[Thymectomy and muscle antibodies in myasthenia gravis].

Romi F, Gilhus NE, Aarli JA.

Tidsskr Nor Laegeforen. 2004 Mar 4;124(5):629-31. Norwegian.

7.

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.

Mygland A, Vincent A, Newsom-Davis J, Kaminski H, Zorzato F, Agius M, Gilhus NE, Aarli JA.

Arch Neurol. 2000 Apr;57(4):527-31.

PMID:
10768628
8.

Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes.

Skeie GO, Pandey JP, Aarli JA, Gilhus NE.

Autoimmunity. 1997;26(2):111-6.

PMID:
9546812
9.

Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.

Skeie GO, Lunde PK, Sejersted OM, Mygland A, Aarli JA, Gilhus NE.

Muscle Nerve. 1998 Mar;21(3):329-35.

PMID:
9486861
10.

Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.

Romi F, Bø L, Skeie GO, Myking A, Aarli JA, Gilhus NE.

J Neuroimmunol. 2002 Jul;128(1-2):82-9.

PMID:
12098514
11.

Titin and ryanodine receptor antibodies in myasthenia gravis.

Skeie GO, Aarli JA, Gilhus NE.

Acta Neurol Scand Suppl. 2006;183:19-23. Review.

PMID:
16637922
12.

Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.

Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA.

Ann N Y Acad Sci. 2003 Sep;998:481-90.

PMID:
14592917
13.

Muscle autoantibodies in subgroups of myasthenia gravis patients.

Romi F, Skeie GO, Aarli JA, Gilhus NE.

J Neurol. 2000 May;247(5):369-75.

PMID:
10896269
14.

Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.

Romi F, Skeie GO, Gilhus NE, Aarli JA.

Arch Neurol. 2005 Mar;62(3):442-6. Review.

PMID:
15767509
15.

Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.

Gunji K, Skolnick C, Bednarczuk T, Benes S, Ackrell BA, Cochran B, Kennerdell JS, Wall JR.

Clin Immunol Immunopathol. 1998 Jun;87(3):276-81.

PMID:
9646837
16.

Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.

Mygland A, Aarli JA, Matre R, Gilhus NE.

J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):843-6.

17.

Titin antibodies in patients with late onset myasthenia gravis: clinical correlations.

Skeie GO, Mygland A, Aarli JA, Gilhus NE.

Autoimmunity. 1995;20(2):99-104.

PMID:
7578874
18.

Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features.

Romi F, Aarli JA, Gilhus NE.

Eur J Neurol. 2007 Jun;14(6):617-20.

PMID:
17539937
19.

Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients.

Yamamoto AM, Gajdos P, Eymard B, Tranchant C, Warter JM, Gomez L, Bourquin C, Bach JF, Garchon HJ.

Arch Neurol. 2001 Jun;58(6):885-90.

PMID:
11405802
20.

Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.

Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA.

Eur J Neurol. 2002 Jan;9(1):55-61.

PMID:
11784377

Supplemental Content

Support Center